Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 39
- Registration Number
- NCT04775121
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
🇫🇷Hôpital Saint Louis, Paris, France
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 1100
- Registration Number
- NCT04567446
- Locations
- 🇫🇷
Hôpital Foch, Suresnes, France
🇫🇷Gustave Roussy, Villejuif, Val De Marne, France
🇫🇷Clinique du Flandre, Coudekerque-Branche, France
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 750
- Registration Number
- NCT04477681
- Locations
- 🇫🇷
CHU Lyon, Lyon, France
🇫🇷Institut Curie, Paris, France
🇫🇷CHU Strasbourg, Strasbourg, France
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 150
- Registration Number
- NCT04349293
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients
- First Posted Date
- 2020-04-10
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT04341207
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 220
- Registration Number
- NCT04304924
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 130
- Registration Number
- NCT04276376
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Pediatric Hepatic Tumors
Recruiting
- Conditions
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 600
- Registration Number
- NCT04274868
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 25
- Registration Number
- NCT04270864
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 41
- Registration Number
- NCT04267146
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷Centre Oscar Lambret, Lille, France
🇫🇷Centre Léon Bérard, Lyon, France
© Copyright 2024. All Rights Reserved by MedPath